AI is reshaping how software is built in life sciences—but most organizations are still operating with governance and validation models designed for a pre-AI world.
Join Bryan Ennis, Sware Co-Founder and Chief Quality Officer, for a LinkedIn Live conversation with Martin Heitmann, ISPE Secretary of the GAMP Global SIG Software Automation & Artificial Intelligence and Managing Director of MH Consulting & Advisory as they explore what life sciences organizations must put in place today to safely and successfully adopt AI.
From AI-assisted development to agentic systems and rapidly evolving platforms like Salesforce, the pace of change is accelerating. But without the right strategy, governance, and validation foundations, AI initiatives risk creating compliance exposure instead of competitive advantage.
Designed for pharma executives, quality and validation leaders, and digital transformation teams, this conversation provides practical insights on how to build an AI strategy that delivers innovation without compromising compliance.
If your organization is exploring AI—or already implementing it—this discussion will help you understand what it truly takes for life sciences to win in the AI era.
